Lithuania Peripheral Vascular Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, Atherectomy Devices, Embolic Protection Devices, Inferior Vena Cava Filters & Others), By End Users (Hospitals and Clinics, Specialty Clinics, Ambulatory Care Centers & Others) and Country

Lithuania peripheral vascular market size was valued at US$ 141.9 million in 2023 and is projected to reach a value of US$ 201.0 million by 2030, at a CAGR of 5.1% from 2024-2030. The market is the market for medical devices used to diagnose and treat peripheral vascular diseases. These diseases include peripheral artery disease (PAD), which can cause blockages in blood vessels outside the brain and heart.

The market is driven by the increasing prevalence of peripheral artery disease (PAD) and other vascular conditions, primarily due to rising obesity rates, diabetes, and an aging population. Technological advancements in device design, such as drug-eluting stents and minimally invasive procedures, have also contributed to market growth. However, the market faces challenges like high costs of advanced devices and procedure-related expenses, despite these challenges, there are significant opportunities in Lithuania's peripheral vascular market, where increasing awareness and government support for disease screening and diagnosis are driving demand. Trends in the market include a shift towards less invasive treatment options and the development of new technologies to improve patient outcomes.

Key Players

The leading companies highlighted in the Lithuania peripheral vascular market report include such as Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic, Philips N.V., and others. Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach.

Key Takeaways

• Based on product type, peripheral vascular stents are dominant in 2023.
• Based on end users, the hospitals and clinics segment is expected to dominate the Egypt packaging market in the coming forecast years.

Key Developments

In September 2021, Abbott acquired Walk Vascular, LLC to expand peripheral vascular offerings and incorporate them into Abbott's existing endovascular product portfolio. 

Lithuania Peripheral Vascular Market Segmentation

By Product Type: Among the listed devices, peripheral vascular stents are the most widely used in the market. These stents are crucial for treating peripheral artery disease (PAD) by keeping the arteries open and ensuring proper blood flow. Their popularity is due to their effectiveness in reducing symptoms like leg pain and improving the quality of life for patients with PAD. The high demand for minimally invasive treatment options and advancements in stent technology have further solidified their dominant position in the market

By End-user: Among all the end users, hospitals and clinics are the most widely used in the market. This is because they are the primary locations for diagnosing and treating peripheral vascular diseases (PVDs), such as peripheral artery disease (PAD). Hospitals and clinics have the necessary infrastructure, including advanced imaging and surgical equipment, to perform procedures like angioplasty, stenting, and atherectomy. Additionally, they have specialized vascular surgeons and interventional radiologists who are trained to handle these complex procedures. The high patient volume and the critical nature of vascular conditions make hospitals and clinics the most common setting for peripheral vascular treatments.